Open access
333
Views
7
CrossRef citations to date
0
Altmetric
Review
Recent Progress in the Development of Opaganib for the Treatment of Covid-19
Charles D Smith1 Apogee Biotechnology Corporation, Hummelstown, PA, USACorrespondence[email protected]
, Lynn W Maines1 Apogee Biotechnology Corporation, Hummelstown, PA, USA
, Staci N Keller1 Apogee Biotechnology Corporation, Hummelstown, PA, USA
, Vered Katz Ben-Yair2 RedHill Biopharma LTD, Tel Aviv, Israel
, Reza Fathi2 RedHill Biopharma LTD, Tel Aviv, Israel
, Terry F Plasse2 RedHill Biopharma LTD, Tel Aviv, Israel
& Mark L Levitt2 RedHill Biopharma LTD, Tel Aviv, Israel
https://orcid.org/0000-0002-5141-0451
Pages 2199-2211
|
Published online: 12 Jul 2022
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.